News

Published Studies Reveal New Data About Edema Reduction,Patient Satisfaction and Quality of Life With Dayspring System

OAKLAND, Calif., Oct. 4, 2022 —Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric platforms, today announced two clinical data publications for the treatment of lymphedema and venous disease with its Dayspring® active compression system, including results from the multi-center, randomized, crossover head-to-head

Published Studies Reveal New Data About Edema Reduction,Patient Satisfaction and Quality of Life With Dayspring System Read More »

LimiFlexTM IDE Clinical Trial Investigator to Present Positive Findings at the North American Spine Society Annual Meeting — Empirical Spine

San Carlos, Calif. (October 6, 2022) – Empirical Spine, Inc., a medical device company creating a new class of spinal implant that works in parallel with the natural structures of the spine to restore functionality and optimize quality of life, will highlight its LimiFlex™ Dynamic Sagittal Tether™ (DST) at the North American Spine Society (NASS)

LimiFlexTM IDE Clinical Trial Investigator to Present Positive Findings at the North American Spine Society Annual Meeting — Empirical Spine Read More »

Channel Medsystems Announces First Endometrial Ablation Procedures in Europe with the Cerene® Cryotherapy Device

Channel Medsystems Announces First Endometrial Ablation Procedures in Europe with the Cerene® Cryotherapy Device BERKELEY, Calif., DATE – Channel Medsystems, Inc., a medical device company whose mission is to empower every woman to take control of her health journey, today announced that the first procedures in Europe were performed with the Cerene® Cryotherapy Device for

Channel Medsystems Announces First Endometrial Ablation Procedures in Europe with the Cerene® Cryotherapy Device Read More »

Sight Sciences Announces Publication of Data Showcasing Superior Symptoms Improvements with the TearCare® System Compared to LipiFlow* in Patients with Advanced Dry Eye Disease (DED)

MENLO PARK, Calif., Sept. 29, 2022 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives today announced Clinical Ophthalmology has published data from a subgroup analysis of the OLYMPIA trial, which showed a single treatment with the TearCare System

Sight Sciences Announces Publication of Data Showcasing Superior Symptoms Improvements with the TearCare® System Compared to LipiFlow* in Patients with Advanced Dry Eye Disease (DED) Read More »

Potrero Medical Receives FDA Breakthrough Device Designation for Accuryn AKI Predict Algorithm

HAYWARD, Calif., Sept. 13, 2022 – Potrero Medical announced today that the FDA granted Breakthrough Device Designation for their AKI Predict machine learning algorithm, for the advanced prediction of acute kidney injury (AKI) associated with intra-abdominal hypertension (IAH) in cardiac post-surgical intensive care patients. “We are excited about the designation, and what this means for patients, providers

Potrero Medical Receives FDA Breakthrough Device Designation for Accuryn AKI Predict Algorithm Read More »

Sight Sciences Introduces the SION™ Surgical Instrument – The First Bladeless Device Used in Goniotomy

MENLO PARK, Calif., August 23, 2022 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative solutions intended to transform care and improve patients’ lives, today announced the launch of SION, a surgical instrument representing a new chapter in goniotomy innovation and practice. Sight Sciences is a

Sight Sciences Introduces the SION™ Surgical Instrument – The First Bladeless Device Used in Goniotomy Read More »

Sight Sciences Announces Long-Term Safety and Effectiveness Data of Standalone Use of the OMNI® Surgical System in Patients with Open Angle Glaucoma

MENLO PARK, Calif., Aug. 16, 2022 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative solutions intended to transform care and improve patients’ lives, today announced 36-month post-surgery follow-up results of the OMNI® Surgical System. The data demonstrates that the OMNI Surgical System delivers safe, consistent,

Sight Sciences Announces Long-Term Safety and Effectiveness Data of Standalone Use of the OMNI® Surgical System in Patients with Open Angle Glaucoma Read More »

Sight Sciences Reports Second Quarter 2022 Financial Results

MENLO PARK, Calif., Aug. 11, 2022 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, today reported financial results for the second quarter ended June 30, 2022.  Recent Business Highlights Generated total revenue of $17.2 million in the second

Sight Sciences Reports Second Quarter 2022 Financial Results Read More »

Long-term Clinical Outcomes with Cerene Cryotherapy

Channel Medsystems Announces Publication of Long-term Clinical Outcomes with Cerene® Cryotherapy for the Treatment of Heavy Menstrual Bleeding Cerene Cryotherapy is clinically proven to significantly reduce menstrual bleeding and premenstrual symptoms safely and effectively with high patient satisfaction through 36 months following treatment BERKELEY, Calif.–(BUSINESS WIRE)–Channel Medsystems, Inc., a medical device company whose mission is

Long-term Clinical Outcomes with Cerene Cryotherapy Read More »

Heather Knight Joins Channel Medsystems Board of Directors

Berkeley, California August 3, 2022  Channel Medsystems, Inc., a medical device company whose mission is to empower every woman to take control of her health journey, today announced that Heather Knight has joined the company’s Board of Directors. “We are pleased to welcome Heather to our Board of Directors,” said Chief Executive Officer Ric Cote. “Heather

Heather Knight Joins Channel Medsystems Board of Directors Read More »